The Gamble of a PhD Hiatus
Pressure to barrel through a PhD can make taking a break seem daunting — but there are ways to limit career damage.
Send us a link
Pressure to barrel through a PhD can make taking a break seem daunting — but there are ways to limit career damage.
Davide Vannoni is barred from offering a controversial stem-cell therapy in Italy but may be continuing his work abroad.
Biologists in particular are writing their papers in a less formal style.
Cap at current spending levels could spell 'end of science in Brazil', researchers say.
The move by Chinese scientists could spark a biomedical duel between China and the United States.
Journal experiments and surveys suggest scientists are coming round to the idea of publishing review reports. A few journals, such as PeerJ, the BMJ and F1000Research, already embrace open peer review in various different forms.
Nine experts reflect on where researchers should direct their efforts during the next US administration.
The majority of our authors are opting in to publish reviewer reports of their papers.
Biomedical funders worldwide are adopting the US agency’s free Relative Citation Ratio to analyse grant outcomes.
World Health Organization asks research initiatives to focus on translating their findings into clinical benefits.
Computerized search of trial registry lists worst offenders.
Calculation suggests papers with women first-authors have citation rates pushed down by 10%.
Tips from Nature Research editors.
New equation also suggests way to predict a researcher's potential to produce top work.
Published chart integrates data from outside scientists.
Upheaval in the former superpower is bad for research and the wider world.
A vibrant scientific culture encourages many interpretations of evidence.
Many biologists are founding their own firms as venture capitalists show increased interest in science.
The creators of the Open Syllabus Project hope that sharing data can both improve and reward teaching.
Cull of papers follows similar discoveries in 2015.
An MP’s dismissive tweet that scientists have ‘no experience of the real world’ highlights a chasm in mutual understanding.
Scientists starting labs say that they are under historically high pressure to publish, secure funding and earn permanent positions — leaving precious little time for actual research.
Demand for steady output stymies discovery. To pursue the most important research, scientists must be allowed to shift their focus.
The research enterprise sometimes keeps scientists from pursuing the best ideas: intense competition forces researchers to prioritize publishing papers over tackling important questions. A special issue explores the problems facing early and mid-career scientists, and how to solve them.